HomeNDC LookupRxCUI directory › RxCUI 1862220

10 ML procainamide hydrochloride 100 MG/ML Prefilled Syringe — RxCUI 1862220

RxNorm drug concept · Semantic clinical drug
RxCUI 1862220 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1862220
Official name10 ML procainamide hydrochloride 100 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprocainamide HCl 1000 MG per 10 ML Prefilled Syringe; procainamide HCl 1000 MG in 10 ML Prefilled Syringe
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Procainamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Procainamide injection is used when your heart needs to be brought back into a safe rhythm quickly — faster than a pill could work. IV delivery gets the medication into your bloods...
  • Why am I getting this medication through an IV or a shot instead of a pill?
  • The most urgent things to report right away are fever, chills, sore throat, mouth sores, unusual bruising, or bleeding — these could signal a dangerous drop in your white blood cel...
  • What side effects should I watch out for while I'm on this medication?
📖 Read our full Procainamide guide →

🕸️ Concept Web — How 10 ML procainamide hydrochloride 100 MG/ML Prefi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML procainamide hydrochloride 100 MG/ML Prefilled Syringe RxCUI 1862220

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Procainamide 8700
    • Procainamide hydrochloride 155056
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Procainamide Prefilled Syringe 1862219
    • Procainamide hydrochloride Prefilled Syringe 2646914
    • Procainamide Injectable Product 1161726
    • Procainamide hydrochloride Injectable Product 2659286
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Procainamide hydrochloride 100 MG/ML 857885

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Procainamide hydrochloride 100 MG/ML SCDC · 857885
  • Procainamide Prefilled Syringe SCDF · 1862219
  • Procainamide hydrochloride Prefilled Syringe SCDFP · 2646914
  • Procainamide Injectable Product SCDG · 1161726
  • Procainamide hydrochloride Injectable Product SCDGP · 2659286

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1862220 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51662-1630-03 5 POUCH in 1 CASE (51662-1630-3) / 1 BOX in 1 POUCH (51662-... PROCAINAMIDE HYDROCHLORIDE HF Acquisition Co LLC, DBA HealthFirst 2023-06-23
70518-4208-00 5 SYRINGE in 1 PACKAGE (70518-4208-0) / 10 mL in 1 SYRINGE... Procainamide Hydrochloride REMEDYREPACK INC. 2024-10-10
76329-3399-05 5 SYRINGE in 1 PACKAGE (76329-3399-5) / 10 mL in 1 SYRINGE Procainamide Hydrochloride International Medication Systems, Limited 2016-12-21
84549-0399-05 10 mL in 1 SYRINGE (84549-399-05) Procainamide Hydrochloride ProPharma Distribution 2025-09-01
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (1) · International Medication Systems, Limited (1) · ProPharma Distribution (1) · REMEDYREPACK INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2690 Procainamide hcl injection 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.